When Lawsuits Become Portfolio Assets
Litigation finance – the practice of third parties funding legal claims in exchange for a share of any eventual settlement or judgment – has spent the better part of two decades operating at the margins of institutional investing. Hedge funds and specialty boutiques were its earliest champions, drawn to returns that had little to do with interest rates, earnings cycles, or equity markets. Now a different category of investor is paying serious attention: university endowments, which manage pools of capital that must compound reliably across generations and weather every macro storm imaginable.
The appeal is structural. A commercial lawsuit filed today might resolve in three to five years, and its outcome depends on evidence, legal argument, and judicial interpretation – not on Federal Reserve policy or corporate profit margins. That independence from financial markets is exactly what endowment managers are hunting for as correlations across traditional asset classes continue tightening. When stocks and bonds sold off simultaneously through 2022, the search for genuinely uncorrelated return streams accelerated, and litigation finance moved from a curiosity to a serious allocation candidate.
How the Asset Class Actually Works
The mechanics are straightforward in principle. A litigation finance firm evaluates a legal claim – often a commercial dispute, patent infringement case, or antitrust matter – and if the merits look strong, it provides capital to the claimant to cover legal fees, expert witnesses, and other litigation costs. In return, the funder receives a predetermined share of any recovery, either a fixed multiple of the amount deployed or a percentage of the total award. If the case loses, the funder loses its capital entirely. There is no debt to repay, no interest clock running against the claimant.
That non-recourse structure creates a risk profile unlike almost anything else in a portfolio. The downside is binary – zero recovery – but the upside can be substantial, with internal rates of return on successful cases sometimes running well into double digits. More importantly for endowment managers, that binary risk is diversifiable across a portfolio of cases. A fund holding stakes in fifty or a hundred ongoing matters has exposure spread across different jurisdictions, legal theories, and industries, none of which are correlated to one another or to the broader economy.
The due diligence process is where litigation finance diverges most sharply from conventional asset management. Instead of analyzing financial statements or modeling discounted cash flows, investment committees are reviewing legal merits, assessing the credibility of law firms, estimating potential damages, and stress-testing opposing arguments. The largest funders employ teams of former litigators, judges, and damages experts. For endowments building direct exposure, that expertise gap is a real barrier – most rely on external managers with established track records rather than building in-house legal analysis capabilities.
Portfolio construction within a litigation fund also involves timeline management that endowment allocators need to understand before committing. Cases do not mature on a schedule. A matter expected to resolve in two years may get caught in appellate proceedings for four more. That J-curve dynamic, familiar from private equity, applies here too, but with less predictability around the cash flow timing. Endowments with permanent capital and long time horizons are better suited to absorb this uncertainty than, say, a corporate pension fund with fixed near-term liabilities.
Why Endowments Are a Natural Fit
University endowments operate on a different logic than most institutional pools. Their investment horizon is theoretically infinite, their liquidity needs are modest relative to total assets, and their mandates typically allow broad access to alternative strategies. The classic endowment model, built around heavy allocations to private equity, venture capital, and real assets, already accepts illiquidity as a feature rather than a bug. Adding litigation finance fits that existing framework without requiring a philosophical overhaul.
The correlation argument carries particular weight for endowments that watched their diversification assumptions fail when they needed them most. Real estate, private credit, and infrastructure all held up better than public equities during past downturns, but they were not immune to macro pressure. Litigation outcomes, by contrast, are driven by facts specific to each case. A global recession does not make a patent any less valid or a breach of contract any less actionable. That insulation from economic cycles is what makes the asset class genuinely additive rather than just another way to own risk with a different label.
The Market Is Maturing – But Slowly
A small number of specialist managers dominate the space, and transparency around performance remains limited compared to more established alternative categories. Most funds do not report mark-to-market valuations in any meaningful way, since the value of an ongoing lawsuit is inherently uncertain until a judgment or settlement is reached. That opacity makes benchmarking difficult and due diligence time-consuming – two realities that have historically kept conservative institutional allocators at arm’s length.
Regulatory risk also hangs over the sector. Several jurisdictions have explored – or actively implemented – disclosure requirements that would force parties in litigation to reveal the existence of third-party funding arrangements. Opponents of litigation finance argue that funded plaintiffs have less incentive to settle reasonably, potentially distorting court dynamics. Supporters counter that access to capital simply levels the playing field against well-resourced defendants. That debate is unresolved, and regulatory changes in key markets like the United States, United Kingdom, or Australia could affect the economics of funded cases in ways that are difficult to model in advance. Endowments moving into the space are accepting that policy risk alongside the legal and duration risks already embedded in the strategy.
Secondary market infrastructure for litigation finance stakes is still thin, which means that an endowment needing to exit a position before cases resolve has limited options. Some larger managers are beginning to develop internal liquidity mechanisms, and there is early-stage activity around securitization of litigation portfolios, but the market has not reached the depth of, say, private credit secondaries. For endowments treating litigation finance as a core allocation rather than a satellite position, that illiquidity premium is part of the return calculation.
What may accelerate broader adoption is simply track record accumulation. The earliest institutional-scale litigation funds are now generating realized returns across full cycles, giving allocators actual data rather than theoretical projections. Endowments that committed to the category five or seven years ago are now seeing case resolutions and can speak to how the asset class performed relative to expectations – and, critically, whether those returns actually arrived uncorrelated to what their equity and credit portfolios were doing at the same time. The answer, so far, appears to be yes. That empirical evidence is worth more to a skeptical investment committee than any amount of conceptual argument about portfolio diversification.
